Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer - Concepedia

Concepedia

Publication | Open Access

Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer

DOI Full Paper Access

152

Citations

28

References

2020

Year

Adrienne G. Waks, Ofir Cohen, Bose Kochupurakkal, D. Kim, Connor E. Dunn, Jorge Buendia, Seth A. Wander, Karla Helvie, Maxwell R. Lloyd, Lori Marini,

Annals of Oncology

References

	Year	Citations

Page 1